Advertisement

Topics

"ABLYNX PRESENT UPCOMING INVESTOR CONFERENCES LONDON PARIS" Drugs and Medication Database

21:21 EST 18th February 2019 | BioPortfolio

Here are the most relevant "ABLYNX PRESENT UPCOMING INVESTOR CONFERENCES LONDON PARIS" Drugs and Medications that we have found in our database.

More Information about "ABLYNX PRESENT UPCOMING INVESTOR CONFERENCES LONDON PARIS" on BioPortfolio

We have published hundreds of ABLYNX PRESENT UPCOMING INVESTOR CONFERENCES LONDON PARIS news stories on BioPortfolio along with dozens of ABLYNX PRESENT UPCOMING INVESTOR CONFERENCES LONDON PARIS Clinical Trials and PubMed Articles about ABLYNX PRESENT UPCOMING INVESTOR CONFERENCES LONDON PARIS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ABLYNX PRESENT UPCOMING INVESTOR CONFERENCES LONDON PARIS Companies in our database. You can also find out about relevant ABLYNX PRESENT UPCOMING INVESTOR CONFERENCES LONDON PARIS Drugs and Medications on this site too.

Showing "ABLYNX PRESENT UPCOMING INVESTOR CONFERENCES LONDON PARIS" Drugs and Medications, all 20

Possibly Relevant

Creon [atlantic biologicals corps]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 2009

Creon [atlantic biologicals corps]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 2009

Creon [atlantic biologicals corps]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 2009

Creon [physicians total care, inc.]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON.CREON (pancrelipase) delayed-release capsules for oral useInitial U.S. Approval: 2009

Creon [abbvie inc.]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON.CREON (pancrelipase) delayed-release capsules for oral useInitial U.S. Approval: 2009

Pertzye [digestive care, inc.]

These highlights do not include all the information needed to use PERTZYE safely and effectively. See full prescribing information for PERTZYE. PERTZYE (pancrelipase) delayed-release capsules, for oral use Initial U.S. Approval: 2012

Podocon 25 [paddock laboratories, llc]

Podocon-25® (25% podophyllin in benzoin tincture)

Pancreaze [vivus, inc.]

These highlights do not include all the information needed to use PANCREAZE safely and effectively. See full prescribing information for PANCREAZE . PANCREAZE (pancrelipase) delayed-release capsules Initial U.S. Approval – 2010

Pancreaze [janssen pharmaceuticals, inc.]

These highlights do not include all the information needed to use PANCREAZE safely and effectively. See full prescribing information for PANCREAZE. PANCREAZE (pancrelipase) delayed-release capsules Initial U.S. Approval – 2010

Zenpep [allergan, inc.]

These highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP.     ZENPEP (pancrelipase) delayed release capsules Initial U.S. Approval:   2009

Hydroquinone [twi pharmaceuticals, inc.]

Hydroquinone USP, 4%

Hydroquinone [preferred pharmaceuticals, inc.]

Hydroquinone USP, 4%

Hydroquinone [bi-coastal pharma international llc]

Hydroquinone USP, 4%

Hydroquinone [syntenza pharmaceuticals llc]

Hydroquinone USP, 4% Skin Bleaching Cream

Dentagel [rising pharmaceuticals, inc.]

DENTAGEL 1.1% 1.1% SODIUM FLUORIDE BRUSH-ON GEL

Viokace [allergan, inc.]

These highlights do not include all the information needed to use VIOKACE safely and effectively. See full prescribing information for VIOKACE VIOKACE(pancrelipase) tablets, for oral useInitial U.S. Approval: 2012

Denta 5000 plus [rising pharmaceuticals, inc.]

DENTA 5000 PLUS BRAND OF 1.1% SODIUM FLUORIDE PRESCRIPTION DENTAL CREAM

Zenpep [physicians total care, inc.]

These highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP. ZENPEP (pancrelipase) delayed release capsules Initial U.S. Approval: 2009

Hydroquinone time release [twi pharmaceuticals, inc.]

Hydroquinone USP, 4% Time Release Cream

Zenpep [allergan]

These highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP. ZENPEP (pancrelipase) delayed release capsules Initial U.S. Approval: 2009



Advertisement
Quick Search
Advertisement
Advertisement